- Home
- AGEN
AGEN
Agenus Inc.
as 05-14-2025 4:00pm EST
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | 52.6M | IPO Year: | 2000 |
| Target Price: | $8.33 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.38 - $19.69 | Next Earning Date: | 05-12-2025 |
| Revenue: | $99,524,000 | Revenue Growth: | -38.34% |
| Revenue Growth (this year): | 14.67% | Revenue Growth (next year): | -4.53% |
Latest Agenus Inc. News
AGEN Breaking Stock News: Dive into AGEN Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
Agenus Inc (AGEN) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges
Thomson Reuters StreetEvents
2 days ago
Q1 2025 Agenus Inc Earnings Call
Zacks
3 days ago
Agenus (AGEN) Reports Q1 Loss, Tops Revenue Estimates
Associated Press Finance
3 days ago
Agenus: Q1 Earnings Snapshot
Business Wire
3 days ago
Agenus Reports Q1 2025 Financial Results and Key Business Updates
Business Wire
3 days ago
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
GuruFocus.com
6 days ago
Agenus Inc (AGEN) Q1 2025: Everything You Need To Know Ahead Of Earnings
Zacks
6 days ago
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Compare AGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AGEN Agenus Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.